Literature DB >> 1398968

Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis.

J W Petersen1, P H Ibsen, K Hasløv, I Heron.   

Abstract

A group of mice was aerosol infected with live, virulent Bordetella pertussis bacteria. During a period of 7 weeks following the infection, with intervals of 1 week, lymphocytes were isolated from the tracheobroncheal lymph nodes (TBL) and the spleens (SPL) of the infected mice. The in vitro proliferative responses as well as the gamma interferon and tumor necrosis factor production levels of the isolated lymphocytes in response to stimulation with whole killed B. pertussis bacteria were measured as parameters for cell-mediated immunity (CMI). The course of the infection was monitored by counting of CFU in the lungs of the mice. Moreover, antibody responses in serum against a range of B. pertussis antigens were assessed. The results showed that a vigorous proliferative response of the TBL and SPL to stimulation with whole killed B. pertussis bacteria was induced by the infection. The proliferative response of the TBL was significantly higher than the response of the SPL. The proliferative responses were maximal 3 to 4 weeks after the infection and were paralleled by in vitro gamma interferon and tumor necrosis factor production upon specific stimulation. The development of the CMI was observed simultaneously with the clearance of the infection from the lungs. Antibody responses became measurable in the sera only after the infection was cleared. A specific CMI against pertussis toxin, the filamentous hemagglutinin, the 69-kDa outer membrane protein, and the agglutinogens 2 and 3, antigens which are under consideration for inclusion in future acellular pertussis vaccines, was successfully demonstrated in mice 3 weeks after the infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398968      PMCID: PMC258203          DOI: 10.1128/iai.60.11.4563-4570.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

Review 1.  Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense. In vitro, in animal models, and in humans.

Authors:  H W Murray
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Sep-Oct       Impact factor: 2.803

2.  Invasion of HeLa 229 cells by virulent Bordetella pertussis.

Authors:  C A Ewanowich; A R Melton; A A Weiss; R K Sherburne; M S Peppler
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

Review 3.  Pertussis vaccine: present status and future prospects.

Authors:  A Robinson; L I Irons; L A Ashworth
Journal:  Vaccine       Date:  1985-03       Impact factor: 3.641

Review 4.  The role of cell-mediated immunity in bacterial infections.

Authors:  H Hahn; S H Kaufmann
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

5.  Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination.

Authors:  M G Thomas; K Redhead; H P Lambert
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

6.  Human cellular immune responses to Bordetella pertussis infection.

Authors:  A J Gearing; C R Bird; K Redhead; M Thomas
Journal:  FEMS Microbiol Immunol       Date:  1989-03

7.  Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization.

Authors:  K Saukkonen; C Cabellos; M Burroughs; S Prasad; E Tuomanen
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

8.  The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes: II. Nature of the responding cells.

Authors:  A S Kong; S I Morse
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

9.  MHC-restricted recognition of immunogenic T cell epitopes of pertussis toxin reveals determinants in man distinct from the ADP-ribosylase active site.

Authors:  J R Oksenberg; A K Judd; C Ko; M Lim; R Fernandez; G K Schoolnik; L Steinman
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

10.  Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis.

Authors:  R D Shahin; M J Brennan; Z M Li; B D Meade; C R Manclark
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  14 in total

1.  Cellular immunity in adolescents and adults following acellular pertussis vaccine administration.

Authors:  Claudius U Meyer; Fred Zepp; Michael Decker; Martin Lee; Swei-Ju Chang; Joel Ward; Sandra Yoder; Hugues Bogaert; Kathryn M Edwards
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

Review 2.  Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacy.

Authors:  Kerrie Vaughan; Emily Seymour; Bjoern Peters; Alessandro Sette
Journal:  Hum Immunol       Date:  2014-02-12       Impact factor: 2.850

3.  Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine.

Authors:  F Zepp; M Knuf; P Habermehl; J H Schmitt; C Rebsch; P Schmidtke; R Clemens; M Slaoui
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

4.  Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0.

Authors:  A Barnard; B P Mahon; J Watkins; K Redhead; K H Mills
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

5.  Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection.

Authors:  Carey E Connelly; Yezhou Sun; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

6.  Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection.

Authors:  E T Harvill; P A Cotter; J F Miller
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines.

Authors:  C M Ausiello; F Urbani; A la Sala; R Lande; A Cassone
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

8.  Circulating fibronectin and fibronectin receptor in children with pertussis.

Authors:  D Torre; M Giola; C Zeroli; R Martegani; G Bonetta; G Ferrario
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

9.  T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.

Authors:  C M Ausiello; R Lande; P Stefanelli; C Fazio; G Fedele; R Palazzo; F Urbani; P Mastrantonio
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

10.  Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.

Authors:  K Redhead; J Watkins; A Barnard; K H Mills
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.